Cargando…

Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial

This randomized clinical trial evaluates the success rate of neuro-adaptive therapy (NAT), applied with a specific neuro-adaptive regulator device, the Self-Controlled Electro Neuro-Adaptive Regulation (SCENAR), versus a sham for urge incontinence due to an overactive bladder (OAB). From February 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Zapico, Álvaro, Ercilla, Julia, Angulo, Javier C., Pérez, Vicente, Cuenca, Juan Nicolás, Barreira-Hernández, Diana, Udina-Cortés, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917375/
https://www.ncbi.nlm.nih.gov/pubmed/36769409
http://dx.doi.org/10.3390/jcm12030759
_version_ 1784886350836662272
author Zapico, Álvaro
Ercilla, Julia
Angulo, Javier C.
Pérez, Vicente
Cuenca, Juan Nicolás
Barreira-Hernández, Diana
Udina-Cortés, Carlos
author_facet Zapico, Álvaro
Ercilla, Julia
Angulo, Javier C.
Pérez, Vicente
Cuenca, Juan Nicolás
Barreira-Hernández, Diana
Udina-Cortés, Carlos
author_sort Zapico, Álvaro
collection PubMed
description This randomized clinical trial evaluates the success rate of neuro-adaptive therapy (NAT), applied with a specific neuro-adaptive regulator device, the Self-Controlled Electro Neuro-Adaptive Regulation (SCENAR), versus a sham for urge incontinence due to an overactive bladder (OAB). From February 2019 to May 2021, 66 patients were recruited. All subjects were randomized 1:1 at the first intervention visit to the NAT or sham procedure. Inclusion criteria were females between 18 and 80 years old with leakages due to an overactive bladder with unresponsiveness to medical therapy. Subjects were scheduled to receive up to eight weekly 20 min intervention sessions to obtain a complete (CR) or partial response (PR). Patients with no response after three sessions were considered as a failure. The primary end point of this trial was to assess the efficacy of NAT compared to an inactive sham intervention, evaluated 1 month after the last session. Analysis showed 23 (70%) patients responded (20 complete and 3 partial response) in the NAT group compared to 16 (48%) patients (all complete response) in the placebo arm (p = 0.014). Significant differences were maintained after the intervention, with persistent response at 3 months in 19 (58%) patients after active treatment and 14 (42%) after the placebo (p < 0.001), and at 6 months in 18 (55%) vs. 11 (33%) (p = 0.022), respectively. The number of sessions to achieve CR was similar in both arms, with 4.3 ± 1.9 in NAT and 3.9 ± 1.8 in the sham group (NS). Significant differences were observed between both groups for patients’ satisfaction (p = 0.01). The binary model selected age as a predictor of response at the last follow-up. The odds ratio indicates that each year of increase in age, the probability of a positive response to treatment at 6 months decreases 0.95 (95% CI 0.9–0.99) times (p = 0.03). In conclusion, this pilot randomized trial gives evidence that neuro-adaptive electrostimulation is effective to treat refractory urge urinary incontinence due to OAB. The security and long-term efficacy of this treatment merits further evaluation. Moreover, its favorable profile and the economic advantages of the device make the evaluation of this promising technique mandatory in a primary therapeutic scenario.
format Online
Article
Text
id pubmed-9917375
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99173752023-02-11 Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial Zapico, Álvaro Ercilla, Julia Angulo, Javier C. Pérez, Vicente Cuenca, Juan Nicolás Barreira-Hernández, Diana Udina-Cortés, Carlos J Clin Med Article This randomized clinical trial evaluates the success rate of neuro-adaptive therapy (NAT), applied with a specific neuro-adaptive regulator device, the Self-Controlled Electro Neuro-Adaptive Regulation (SCENAR), versus a sham for urge incontinence due to an overactive bladder (OAB). From February 2019 to May 2021, 66 patients were recruited. All subjects were randomized 1:1 at the first intervention visit to the NAT or sham procedure. Inclusion criteria were females between 18 and 80 years old with leakages due to an overactive bladder with unresponsiveness to medical therapy. Subjects were scheduled to receive up to eight weekly 20 min intervention sessions to obtain a complete (CR) or partial response (PR). Patients with no response after three sessions were considered as a failure. The primary end point of this trial was to assess the efficacy of NAT compared to an inactive sham intervention, evaluated 1 month after the last session. Analysis showed 23 (70%) patients responded (20 complete and 3 partial response) in the NAT group compared to 16 (48%) patients (all complete response) in the placebo arm (p = 0.014). Significant differences were maintained after the intervention, with persistent response at 3 months in 19 (58%) patients after active treatment and 14 (42%) after the placebo (p < 0.001), and at 6 months in 18 (55%) vs. 11 (33%) (p = 0.022), respectively. The number of sessions to achieve CR was similar in both arms, with 4.3 ± 1.9 in NAT and 3.9 ± 1.8 in the sham group (NS). Significant differences were observed between both groups for patients’ satisfaction (p = 0.01). The binary model selected age as a predictor of response at the last follow-up. The odds ratio indicates that each year of increase in age, the probability of a positive response to treatment at 6 months decreases 0.95 (95% CI 0.9–0.99) times (p = 0.03). In conclusion, this pilot randomized trial gives evidence that neuro-adaptive electrostimulation is effective to treat refractory urge urinary incontinence due to OAB. The security and long-term efficacy of this treatment merits further evaluation. Moreover, its favorable profile and the economic advantages of the device make the evaluation of this promising technique mandatory in a primary therapeutic scenario. MDPI 2023-01-18 /pmc/articles/PMC9917375/ /pubmed/36769409 http://dx.doi.org/10.3390/jcm12030759 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zapico, Álvaro
Ercilla, Julia
Angulo, Javier C.
Pérez, Vicente
Cuenca, Juan Nicolás
Barreira-Hernández, Diana
Udina-Cortés, Carlos
Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
title Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
title_full Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
title_fullStr Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
title_full_unstemmed Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
title_short Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
title_sort effect of neuro-adaptive electrostimulation therapy versus sham for refractory urge urinary incontinence due to overactive bladder: a randomized single-blinded trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917375/
https://www.ncbi.nlm.nih.gov/pubmed/36769409
http://dx.doi.org/10.3390/jcm12030759
work_keys_str_mv AT zapicoalvaro effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial
AT ercillajulia effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial
AT angulojavierc effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial
AT perezvicente effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial
AT cuencajuannicolas effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial
AT barreirahernandezdiana effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial
AT udinacortescarlos effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial